ArticleGynecologic oncology reports2024
The efficacy and safety of lenvatinib plus pembrolizumab therapy in patients with uterine carcinosarcoma.
Risako Ozawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it